InBev-Baillet Latour Fund
InBev-Baillet Latour Fund is a philanthropic organization based in Belgium. It was established in 1974 by the InBev company, one of the world's largest brewing companies, and the Baillet Latour family, a prominent Belgian noble family. The fund's primary aim is to support scientific, medical, and educational projects in Belgium and abroad.
History[edit | edit source]
The InBev-Baillet Latour Fund was established in 1974. The fund was created by the merger of two existing philanthropic entities: the InBev company's corporate philanthropy program and the Baillet Latour family's private foundation. The fund's establishment was part of a broader trend in the 1970s towards increased corporate philanthropy in Belgium.
Activities[edit | edit source]
The InBev-Baillet Latour Fund supports a wide range of projects in the fields of science, medicine, and education. The fund provides grants to researchers, educational institutions, and other organizations. It also awards the InBev-Baillet Latour Health Prize, one of the most prestigious medical prizes in Belgium, which recognizes outstanding contributions to medical research.
Governance[edit | edit source]
The InBev-Baillet Latour Fund is governed by a board of directors, which includes representatives from the InBev company and the Baillet Latour family. The board is responsible for setting the fund's strategic direction and overseeing its activities.
Impact[edit | edit source]
The InBev-Baillet Latour Fund has had a significant impact on scientific, medical, and educational research in Belgium and beyond. The fund's grants have supported groundbreaking research in a variety of fields, and its prizes have recognized some of the most important contributions to medical science.
See also[edit | edit source]
References[edit | edit source]
This philanthropy related article is a stub. You can help WikiMD by expanding it.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD